Mumbai, August 5 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 837.75, up by 28.15 points or 3.48% from its previous closing of Rs. 809.60 on the BSE. The scrip opened at Rs. 820.00 and has touched a high and low of Rs. 840.45 and Rs. 820.00 respectively. So far 198 shares were traded … Read more
Mumbai, July 28 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 818.75, up by 4.30 points or 0.53% from its previous closing of Rs. 814.45 on the BSE. The scrip opened at Rs. 814.45 and has touched a high and low of Rs. 828.70 and Rs. 812.90 respectively. So far 6493 shares were traded … Read more
Mumbai, May 14 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 781.55, up by 13.15 points or 1.71% from its previous closing of Rs. 768.40 on the BSE. The scrip opened at Rs. 765.00 and has touched a high and low of Rs. 791.05 and Rs. 765.00 respectively. So far 7503 shares were traded … Read more
Mumbai, April 23 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 779.00, up by 14.80 points or 1.94% from its previous closing of Rs. 764.20 on the BSE. The scrip opened at Rs. 765.00 and has touched a high and low of Rs. 779.00 and Rs. 763.95 respectively. So far 95 shares were traded … Read more
Mumbai, April 7 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 681.40, up by 25.25 points or 3.85 % from its previous closing of Rs. 656.15 on the BSE. The scrip opened at Rs. 654.80 and has touched a high and low of Rs. 683.30 and Rs. 653.00 respectively. So far 8313 shares were … Read more
Mumbai, March 10 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 715.70, up by 9.30 points or 1.32% from its previous closing of Rs. 706.40 on the BSE. The scrip opened at Rs. 706.10 and has touched a high and low of Rs. 719.95 and Rs. 706.10 respectively. So far 1417 shares were traded … Read more
Mumbai, October 20 (Udaipur Kiran): Shares of Alembic Pharmaceuticals Limited gained over 1% in Monday’s trade after the company received final approval from the U.S. Food and Drug Administration (USFDA) for its Triamcinolone Acetonide Injectable Suspension USP. The stock was trading at Rs. 947.55, up Rs. 10.05 or 1.07% from its previous close of Rs. … Read more